SCHEMBL4144074

SCHEMBL4144074

N#Cc1cccc(/C=C2\SC(=S)N(Cc3ccc4c(c3)OCO4)C2=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.62
▸ KMT2A Q03164 6/20 0.50
▸ MEN1 O00255 5/20 0.50
▸ ATM Q13315 1/20 0.50
▸ CTDSP1 Q9GZU7 2/20 0.48
▸ DDX3X O00571 2/20 0.47
▸ PTPN7 P35236 2/20 0.47
▸ PTPN12 Q05209 2/20 0.47
▸ GPR35 Q9HC97 2/20 0.47
▸ PTPN22 Q9Y2R2 2/20 0.47
▸ DUSP22 Q9NRW4 1/20 0.46
▸ POLB P06746 3/20 0.46
▸ BLM P54132 1/20 0.46
▸ PTPN1 P18031 1/20 0.46
▸ CFTR P13569 1/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4144079 1.00 MAPK1 (0.62) MAPK1KMT2AMEN1ATMCTDSP1
SCHEMBL4133303 0.90 MAPK1 (0.60) MAPK1KMT2AMEN1CTDSP1DDX3X
SCHEMBL4133305 0.90 MAPK1 (0.60) MAPK1KMT2AMEN1CTDSP1DDX3X
SCHEMBL4142283 0.87 MAPK1 (0.67) MAPK1KMT2AMEN1ATMCTDSP1
SCHEMBL4142279 0.87 MAPK1 (0.67) MAPK1KMT2AMEN1ATMCTDSP1
SCHEMBL4138638 0.86 MAPK1 (0.72) MAPK1KMT2AMEN1CTDSP1DDX3X
SCHEMBL4138637 0.86 MAPK1 (0.72) MAPK1KMT2AMEN1CTDSP1DDX3X
SCHEMBL4125367 0.86 MEN1 (0.69) MAPK1KMT2AMEN1ATMCTDSP1
SCHEMBL4125372 0.86 MEN1 (0.69) MAPK1KMT2AMEN1ATMCTDSP1
SCHEMBL4125376 0.86 MEN1 (0.69) MAPK1KMT2AMEN1ATMCTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MAPK1 3035/4885KMT2A 1459/4885MEN1 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback